reference/35098480

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35098480

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	380
issn	1044-1549 1535-4989
issueIdentifier	4
pageRange	366-380
publicationName	American Journal of Respiratory Cell and Molecular Biology
startingPage	366
bibliographicCitation	Watson CK, Schloesser D, Fundel-Clemens K, Lerner C, Gabler S, Baskaran P, Wohnhaas CT, Dichtl S, Huber HJ, Ask K, Gantner F, Viollet C, Thomas MJ, Ramirez F, Murray PJ, El Kasmi KC. Antifibrotic Drug Nintedanib Inhibits CSF1R to Promote IL-4-associated Tissue Repair Macrophages. Am J Respir Cell Mol Biol. 2023 Apr;68(4):366–80. doi: 10.1165/rcmb.2022-0021oc. PMID: 36227799.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a07cb4e312af08cbd8e905b37d9802e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28680feef4f8ee36cb57aea560597e46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f102b8c56bc121b222abcd63c397ad5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b80532feffe26fef04d2a543a5a8d818 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1958-1899 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdb3dbe538b5dbdef541c96eb1bcf85e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4085cc9a396c8713558c4fc917426ae1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6329-9802 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0202-735X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce49c5f6948ab5ccdc8ed7e08f934048 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_259f1b5527acbdccaec9ba35ea9a886c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6085481240a41ddcd13032d934c2922e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5f092448ff8380a6de9b5cad7e316c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3dd2ff723dc9d274eb3088682f883f42 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cc01aa086b4673b5c34d584b27bc0b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5963-0416
date	202304
identifier	https://doi.org/10.1165/rcmb.2022-0021oc https://pubmed.ncbi.nlm.nih.gov/36227799
isPartOf	https://portal.issn.org/resource/ISSN/1044-1549 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1625 https://portal.issn.org/resource/ISSN/1535-4989
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Antifibrotic Drug Nintedanib Inhibits CSF1R to Promote IL-4–associated Tissue Repair Macrophages
discusses	http://id.nlm.nih.gov/mesh/M0024689 http://id.nlm.nih.gov/mesh/M000653803 http://id.nlm.nih.gov/mesh/M0549010 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M0024266
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008264Q000187 http://id.nlm.nih.gov/mesh/D008264Q000378 http://id.nlm.nih.gov/mesh/D007211Q000494 http://id.nlm.nih.gov/mesh/D054990Q000378 http://id.nlm.nih.gov/mesh/D054990Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016173Q000037 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D015847Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360373 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab9bc7ce433266ca5b4543e538aeed73 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155903698 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14591 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aa3b04108f731ef80013fb81d6b5bb98 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84068 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fdf9e942b6ca454f8cceff3e4117f2c9 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456190 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11094 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_69c8365c5e015aa60518d03ac8157056 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135423438 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1466772cb1e0216a97b90e84b70acebf http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460769 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12978

Showing number of triples: 1 to 65 of 65.